Heart-rate-lowering drug ivabradine reduces death when added to treatments in heart failure patients
Sunday, August 29, 2010 - 04:07
in Health & Medicine
The heart-rate-lowering drug ivabradine significantly reduces the risk of cardiovascular death and hospitalisation for worsening heart failure when added to standard treatment in patients with heart failure and a high heart rate, according to the first of two Articles published Online First in The Lancet, and being presented at the European Society of Cardiology Annual Congress in Stockholm. A second Article concludes that a high heart rate is an independent risk factor for heart failure and that lowering of heart rates is an important treatment target for patients with heart failure.